regulatory
confidence high
sentiment negative
materiality 0.75
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV): Nasdaq/NYSE listing notice — Clover Health receives Nasdaq bid price deficiency notice; has until Sep 30, 2024 to regain compliance
CLOVER HEALTH INVESTMENTS, CORP. /DE
- Received Nasdaq notice on April 2, 2024 for CLOV closing below $1.00 for 30 consecutive business days.
- Company has 180 days, until September 30, 2024, to regain compliance via a $1.00 close for 10 consecutive days.
- Options to cure include a reverse stock split (subject to stockholder approval) or transfer to Nasdaq Capital Market.
- If not compliant by Sep 30, may seek a second 180-day period by moving to Nasdaq Capital Market.
- Failure to regain compliance could lead to delisting; appeal rights available.